Efficacy of Chloroquine for the Treatment of Vivax malaria in Northwest Ethiopia.

ABSTRACT:

Background

Resistance to anti-malarials is a major challenge for effective malaria control in sub-Saharan Africa. This triggered a need for routine monitoring of the efficacy of the antimalarial drugs every two years in all malaria endemic countries. Chloroquine remained the drug of choice for the treatment of vivax malaria in Ethiopia. Though, a strong scientific evidence of chloroquine resistance to P.vivax that could have brought change of treatment regimen is yet to be established in Ethiopia, continuous and regular monitoring of drug's efficacy is critical for establishing rational anti-malarial drug policies. This study therefore, assessed the therapeutic efficacy of Chloroquine (CQ) for the treatment of Plasmodium vivax infections in Northwestern Ethiopia.

Methods

An

SUBMITTER: Beyene HB 

PROVIDER: S-EPMC5007045 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature